Association between serum ferritin level and diastolic cardiac function in patients with major beta-thalassemia

被引:0
作者
Eghbali, A. [1 ]
Taherahmadi, H. [2 ]
Bagheri, B. [3 ,4 ]
Nikanjam, S. [5 ]
Ebrahimi, L. [6 ]
机构
[1] Arak Univ Med Sci, Dept Pediat, Pediat Hematologist & Oncologist, Arak, Iran
[2] Arak Univ Med Sci, Dept Pediat, Arak, Iran
[3] Semnan Univ Med Sci, Canc Res Ctr, Semnan, Iran
[4] Semnan Univ Med Sci, Dept Pharmacol, Semnan, Iran
[5] Arak Univ Med Sci, Student Med, Arak, Iran
[6] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran, Iran
关键词
Thalassemia; Ferritin; Echocardiography; Ejection fraction; diastolic dysfunction;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Prevention of myocardial siderosis is a key step to reduce rate of mortality in thalassemic patients. Our objective was to study association between echocardiography parameters and serum ferritin level in patients with major thalassemia. Materials and Methods Sixty-six patients with major thalassemia were studied in Amir Kabir hospital, Arak, Iran. Serum ferritin levels were measured during 3 months in patients with no symptoms of infection. It was measured by enzyme-linked immunosorbent assay (ELISA). Ejection Fraction (EF), Fractional Shortening (FS) and Early/Late ratio (E/A) were studied by echocardiography. Results Fifty two percent were female and 48% were male. Mean age was 16 +/- 9 years and the age range was3-26years. Mean serum ferritin level was1912 +/- 1748 ng/dl and its range was from 303 to 8333 ng/dl. There were significant correlations between serum ferritin level and EF(r=0.3 and P=0.05) and also between serum ferritin level and FS. Conclusion Due to significant association between serum ferritin level and echo parameters, it is beneficial that all patients with major thalassemia undergo echocardiography to gain better understating about cardiac function.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 20 条
  • [1] Cardiac status in well-treated patients with thalassemia major
    Aessopos, A
    Farmakis, D
    Hatziliami, A
    Fragodimitri, C
    Karabatsos, F
    Joussef, J
    Mitilineou, E
    Diamanti-Kandaraki, E
    Meletis, J
    Karagiorga, M
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (05) : 359 - 366
  • [2] ALDOURI MA, 1990, ACTA HAEMATOL-BASEL, V84, P113
  • [3] ATIG M, 2006, SINGAP MED J, V47, P693
  • [4] Berdoukas V, 1984, CLIN APPROACH THALAS, P171
  • [5] PROLONGED SURVIVAL IN PATIENTS WITH BETA-THALASSEMIA MAJOR TREATED WITH DEFEROXAMINE
    EHLERS, KH
    GIARDINA, PJ
    LESSER, ML
    ENGLE, MA
    HILGARTNER, MW
    [J]. JOURNAL OF PEDIATRICS, 1991, 118 (04) : 540 - 545
  • [6] Heart failure in beta thalassemia: A 5-year follow-up study
    Kremastinos, DT
    Tsetsos, GA
    Tsiapras, DP
    Karavolias, GK
    Ladis, VA
    Kattamis, CA
    [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 111 (05) : 349 - 354
  • [7] Ultrastructural pathology of the heart in patients with β-thalassaemia major
    Kyriacou, K
    Michaelides, Y
    Senkus, R
    Simamonian, K
    Pavlides, N
    Antoniades, L
    Zambartas, C
    [J]. ULTRASTRUCTURAL PATHOLOGY, 2000, 24 (02) : 75 - 81
  • [8] Li C K, 2002, Hong Kong Med J, V8, P255
  • [9] Liu P, 1996, CAN J CARDIOL, V12, P155
  • [10] Survival in β-thalassaemia major in the UK:: data from the UK thalassaemia register
    Modell, B
    Khan, M
    Darlison, M
    [J]. LANCET, 2000, 355 (9220) : 2051 - 2052